Institute of Virology of the Slovak Academy of Sciences

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 9197
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 4251
 
  
 
C07K PEPTIDES 3133
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 293
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 2123
 
  
 
C07D HETEROCYCLIC COMPOUNDS 1161

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8025865 CA IX-specific inhibitorsOct 30, 07Sep 27, 11[A61K]
8012707 MN gene and proteinOct 30, 07Sep 06, 11[G01N]
7993852 MN/CA IX and cancer prognosisMay 05, 10Aug 09, 11[G01N]
7910549 MN gene and proteinFeb 17, 06Mar 22, 11[A61K]
7910691 MN gene and proteinOct 30, 07Mar 22, 11[C07K]
7855185 MN gene and proteinOct 31, 07Dec 21, 10[A61K]
7846673 Soluble form of carbonic anhydrase IX (s-CA IX), assays to detect s-CA IX, CA IX'S coexpression with HER-2/neu/c-erbB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopesAug 19, 04Dec 07, 10[G01N]
7838240 MN/CA IX/CA9 and renal cancer prognosisJan 22, 09Nov 23, 10[C12Q, G01N]
7833514 CA IX-specific inhibitorsOct 30, 07Nov 16, 10[A01N]
7833728 Soluble form of carbonic anhydrase IX (s-CA IX), assays to detect s-CA IX, CA IX's coexpression with HER-2/neu/c-erbB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopesOct 31, 07Nov 16, 10[G01N]

View all patents..

Expired/Abandoned/Withdrawn Patents

  • No Patents to Display

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.